Publication: Erratum: A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443)
| dc.contributor.author | Torsak Bunupuradah | en_US |
| dc.contributor.author | Ploenchan Chetchotisakd | en_US |
| dc.contributor.author | Jintanat Ananworanich | en_US |
| dc.contributor.author | Warangkana Munsakul | en_US |
| dc.contributor.author | Supunnee Jirajariyavej | en_US |
| dc.contributor.author | Pacharee Kantipong | en_US |
| dc.contributor.author | Wisit Prasithsirikul | en_US |
| dc.contributor.author | Somnuek Sungkanuparph | en_US |
| dc.contributor.author | Chureeratana Bowonwatanuwong | en_US |
| dc.contributor.author | Virat Klinbuayaem | en_US |
| dc.contributor.author | Stephen J. Kerr | en_US |
| dc.contributor.author | Jiratchaya Sophonphan | en_US |
| dc.contributor.author | Sorakij Bhakeecheep | en_US |
| dc.contributor.author | Bernard Hirschel | en_US |
| dc.contributor.author | Kiat Ruxrungtham | en_US |
| dc.contributor.other | The HIV Netherlands Australia Thailand Research Collaboration | en_US |
| dc.contributor.other | Khon Kaen University | en_US |
| dc.contributor.other | SEARCH | en_US |
| dc.contributor.other | Chulalongkorn University | en_US |
| dc.contributor.other | Bangkok Metropolitan Administration | en_US |
| dc.contributor.other | Taksin Hospital | en_US |
| dc.contributor.other | Chiangrai Prachanukroh Hospital | en_US |
| dc.contributor.other | Bamrasnaradura Infectious Disease Institute | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.contributor.other | Chonburi Regional Hospital | en_US |
| dc.contributor.other | Sanpatong Hospital | en_US |
| dc.contributor.other | University of New South Wales (UNSW) Australia | en_US |
| dc.contributor.other | National Health Security Office | en_US |
| dc.contributor.other | Universite de Geneve | en_US |
| dc.date.accessioned | 2018-06-11T05:20:45Z | |
| dc.date.available | 2018-06-11T05:20:45Z | |
| dc.date.issued | 2012-01-01 | en_US |
| dc.identifier.citation | Antiviral Therapy. Vol.17, No.7 (2012), 1389-1390 | en_US |
| dc.identifier.doi | 10.3851/IMP2452 | en_US |
| dc.identifier.issn | 20402058 | en_US |
| dc.identifier.issn | 13596535 | en_US |
| dc.identifier.other | 2-s2.0-84870565709 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/15122 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84870565709&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
| dc.title | Erratum: A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443) | en_US |
| dc.type | Erratum | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84870565709&origin=inward | en_US |
